{"id":"v920-consistency-lot-b","safety":{"commonSideEffects":[{"rate":"null","effect":"Pain, redness, or swelling at the injection site"},{"rate":"null","effect":"Fatigue"},{"rate":"null","effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"V920 works by introducing a piece of the SARS-CoV-2 virus to the body, which triggers an immune response and helps the body produce antibodies to fight the virus. This immune response can provide protection against COVID-19 and potentially reduce the severity of symptoms if the individual is exposed to the virus.","oneSentence":"V920 is a vaccine designed to protect against COVID-19 by inducing an immune response against the SARS-CoV-2 virus.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:53:59.022Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of COVID-19"}]},"trialDetails":[{"nctId":"NCT02503202","phase":"PHASE3","title":"Evaluation of the Safety and Immunogenicity of Three Consistency Lots and a High-Dose Lot of rVSV-ZEBOV-GP (V920 Ebola Vaccine) in Healthy Adults (V920-012)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2015-08-17","conditions":"Prevention of Ebola Infection","enrollment":1197}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"V920 Consistency Lot B","genericName":"V920 Consistency Lot B","companyName":"Merck Sharp & Dohme LLC","companyId":"merck","modality":"Biologic","firstApprovalDate":"","aiSummary":"V920 is a vaccine designed to protect against COVID-19 by inducing an immune response against the SARS-CoV-2 virus. Used for Prevention of COVID-19.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}